Blog

Study Shows Solid Longterm Outcomes Using MRgFUS to Treat Uterine Fibroids

Published:
A study recently published in the journal Academic Radiology shows positive outcomes up to three years following treatment of uterine fibroids with MR-guided focused ultrasound. In the study, 40 women with fibroids were treated with focused ultrasound. Researchers followed up with the women at three and six months, as well as one, two and three years. They found that the largest decrease in fibroid size occurred within the first six months and continued to happen over the three-year period.
Read More ...

Robertson and Zecher Join FUSF Council

Published:
The Focused Ultrasound Surgery Foundation is delighted to welcome two new Council members, Wyndham Robertson of Chapel Hill, North Carolina, and Linda Zecher of Keswick, Virginia. The FUSF Council is a group of advisors and advocates that supports the work of the Foundation by providing counsel, organizing cultivation events and helping to raise funds and increase public awareness. Wyndham Robertson A staff member at FORTUNE Magazine for 25 years, Wyndham Robertson was its first female assistant managing editor. She covered investments, finance and technology. She also served briefly as the business editor of TIME Magazine.
Read More ...

CHA Medical Center is First to Treat 500 Fibroid Patients; Yonsei University Plans First OCD Trial

Published:
On June 14, 2011, GE Healthcare Korea and InSightec, Ltd. co-hosted a conference to recognize two important developments in the focused ultrasound community. First was the attainment of the 500-patient mark by the focused ultrasound team at CHA Bundang Medical Center in Seoul. Under the leadership of Sang-Wook Yoon, MD, the team has been treating uterine fibroid patients for five years. CHA’s one-year follow up data shows that 95% of patients have experienced improvement and that 18 have either become pregnant or given birth. The second development acknowledged at the event is the purchase of ExAblate brain and body systems by Yonsei University Medical Center. Jin Woo Chang, MD will use the new brain system to conduct the world’s first clinical trial in which patients with obsessive compulsive disorder (OCD) will receive MR-guided focused ultrasound therapy. Yonsei researchers are also planning clinical trials involving patients with metastatic bone tumors, low-risk and intermediate risk prostate cancers, essential tremor, and brain cancer.
Read More ...

FUSF Welcomes Arik Hananel, MD as Scientific and Medical Director

Published:
The Foundation is pleased to welcome Arik Hananel, MD as its new Scientific and Medical Director. Hananel  was involved in the early stages of commercializing MR-guided focused ultrasound at device pioneer InSightec, Ltd. and has more than 12 years of research and development experience with the technology. The pivotal positions Hananel held at InSightec give him a unique vantage point for advancing the Foundation’s mission: he is familiar with the clinical research funded by the Foundation, understands how the technology is evolving and has long-standing relationships with the key stakeholders in the field. Arik Hananel, MD “We are excited about the leadership role that Dr. Hananel will play at the Foundation. His in-depth knowledge of many facets of MR-guided focused ultrasound will be invaluable in helping to facilitate the adoption of this game-changing technology,” says Foundation Chairman Neal F. Kassell, MD. Hananel’s primary responsibilities will be overseeing research activities, including pre-clinical studies and clinical trials, and representing the Foundation at meetings and symposia. Hananel is passionate about accelerating the adoption of MR-guided focused ultrasound. “It can change medicine in a way that will benefit almost every patient,” he observes. “I remember seeing the first uterine fibroid treatments, and thinking about the contrast of the long recovery processes involved in other, more invasive procedures. I would watch a woman get treated with MR-guided focused ultrasound. Thirty-minutes later, I would be sitting with her, talking and joking. It continues to amaze me, even today. “Once you see a patient receive the treatment, it changes your perspective completely. You need to see the person and not the procedure,” he says. This enthusiasm for patients is natural to Hananel. Though his career has been in the corporate world, he trained as a clinical MD and almost became a pediatrician. However, as he says, “fate intervened” when he accepted a position at InSightec. He is pleased that his new post at the Foundation will allow him to combine his medical degree with his two other degrees: a Bachelor’s of Computer Science and an Executive MBA. Aside from the great career fit, he considers the opportunity to be a personal “adventure.” Hananel, his wife, and three boys – ages 6, 11 and 14 – are relocating from their native Israel to Charlottesville, Virginia for the next chapter of their lives. Written by Ellen C., McKenna
Read More ...
Arkansas Researcher is Exploring FUS as an Adjuvant Therapy to Radiation FUSF Funding Two Clinical Trials at Sunnybrook Health Sciences Centre FUS Research Proposals Reach a Record Pace Video Features World's First Essential Tremor Patient Treated with MR-guided Focused Ultrasound Advances in Therapeutic and Diagnostic Ultrasound is Topic of Special AAPM Symposium, Aug. 1-3, 2011